Anti-CD20 monoclonal antibody (Rituximab) for life-threatening hemolytic-uremic syndrome.
about
Thrombotic microangiopathy after kidney transplantation.Protein A immunoadsorption therapy for refractory, mitomycin C-associated thrombotic microangiopathy.Rituximab for managing relapsing or refractory patients with idiopathic thrombotic thrombocytopenic purpura--haemolytic uraemic syndromeComplement activation during liver transplantation-special emphasis on patients with atypical hemolytic uremic syndrome.The emerging role of rituximab in organ transplantation.Critical care perspective on immunotherapy in lung transplantation.
P2860
Anti-CD20 monoclonal antibody (Rituximab) for life-threatening hemolytic-uremic syndrome.
description
2005 nî lūn-bûn
@nan
2005 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
Anti-CD20 monoclonal antibody (Rituximab) for life-threatening hemolytic-uremic syndrome.
@ast
Anti-CD20 monoclonal antibody (Rituximab) for life-threatening hemolytic-uremic syndrome.
@en
type
label
Anti-CD20 monoclonal antibody (Rituximab) for life-threatening hemolytic-uremic syndrome.
@ast
Anti-CD20 monoclonal antibody (Rituximab) for life-threatening hemolytic-uremic syndrome.
@en
prefLabel
Anti-CD20 monoclonal antibody (Rituximab) for life-threatening hemolytic-uremic syndrome.
@ast
Anti-CD20 monoclonal antibody (Rituximab) for life-threatening hemolytic-uremic syndrome.
@en
P2093
P2860
P1476
Anti-CD20 monoclonal antibody (Rituximab) for life-threatening hemolytic-uremic syndrome.
@en
P2093
P2860
P304
P356
10.1111/J.1399-0012.2005.00334.X
P577
2005-06-01T00:00:00Z